Read this part first

If you have urinary symptoms, get them evaluated. Do not assume they are hormonal.

Seek care promptly for any of the following:

●      fever, chills, or back or flank pain

●      blood in the urine

●      pain with urination that is new or worsening

●      symptoms that persist, recur, or escalate

Untreated urinary tract infections can ascend to the kidneys, and infections in older women can present atypically. A urine test is quick, and it is the only thing that answers this question.

What follows explains why these symptoms can occur without infection. It is not a way to avoid testing. It is context for the situation many women find themselves in: repeated cultures that come back negative, and symptoms that are entirely real.

Why the confusion happens

Most women are taught to think of the urinary tract and the genital tract as separate systems. Developmentally they are not, and — importantly — they share hormone responsiveness.

The urethra, the bladder trigone, and surrounding supportive tissue all carry receptors for the same hormones that act on vulvar and vaginal tissue.[1,2] When the hormonal environment changes in midlife, these tissues change too. Not as a side effect. As part of the same process.

This is why the clinical term is genitourinary syndrome of menopause rather than the older, narrower "vulvovaginal atrophy." The 2014 consensus definition explicitly names the urethra and bladder among affected tissues, and lists urgency, dysuria, and recurrent urinary tract infections among the syndrome's urinary symptoms.[1] The urinary component was recognized as part of the same biology.

What changes, and why it produces these particular symptoms

Thinning of the urethral lining. The urethra is lined with hormone-responsive tissue. As it thins, it becomes more sensitive to the passage of urine — producing burning without any organism present.[1,3]

Reduced tissue cushioning. Supportive tissue around the urethra contributes to its normal closure and comfort. As this changes, sensation changes with it.

Altered sensory signaling. The nerves reporting from this region change their responsiveness. Signals that were previously below the threshold of awareness can begin to register as urgency or discomfort.

A shifted vaginal microbial environment. As glycogen availability falls, Lactobacillus populations decline and vaginal pH rises. This changes which organisms are present near the urethral opening.[2]

That last point deserves emphasis, because it cuts against the reassurance the rest of this article might seem to offer: midlife makes genuine infections more likely at the same time as it produces infection-like symptoms without infection. Both are true simultaneously. Vaginal estrogen has been shown in randomized trials to reduce the incidence of urinary tract infection in postmenopausal women with recurrent UTI, precisely by restoring this tissue environment.[2] That is why testing matters more in midlife, not less.

The pattern women describe

Symptoms appear. A UTI seems obvious. A culture is ordered — negative. Antibiotics are sometimes given anyway. Symptoms improve briefly, or don't, and return. The cycle repeats, sometimes for years, often with the growing suspicion that no one believes the symptoms are real.

They are real. A negative culture does not mean nothing is happening. It means the cause is not the organism that was tested for.

This distinction is worth carrying into a clinical appointment, because it changes the question from "do I have an infection?" to "if this isn't infection, what tissue change would explain it?" — and that is a question a clinician can work with.

What to bring to that appointment

●      when symptoms occur, and whether anything reliably triggers them

●      whether cultures have been done, and what they showed

●      whether you have vulvar or vaginal symptoms alongside the urinary ones — dryness, irritation, discomfort with intimacy

●      what has been tried and what happened

That third point matters most. Urinary symptoms appearing alongside vulvovaginal symptoms point toward a shared hormonal mechanism rather than an isolated urinary problem [1] — and that pattern is often the thing that reframes the whole picture.

Where vulvar care fits, and where it doesn't

Caring for external vulvar tissue can make the whole area feel more comfortable, and for some women that meaningfully changes daily experience.

But the boundary needs to be explicit: a vulvar moisturizer does not treat infection, does not prevent infection, and does not replace urine testing or medical care. Restore is designed to moisturize and condition dry or sensitive external vulvar tissue. 

If an infection is present, it needs treatment. If it isn't, that is worth establishing properly — because knowing what you are dealing with is what makes anything else possible.

For further education on midlife urinary and vulvovaginal health, VULVAi, led by our medical advisor Dr. Maria Uloko, is a good resource.

Educational note: This content is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any medical condition. Urinary symptoms require evaluation by a qualified healthcare provider.

By Laura Kelly, DAOM, L.Ac., Dipl. OM — Double board-certified clinician in women's health and aging. Research Scholar, Ronin Institute. Developer of the Drive–Capacity Model of midlife female sexual function. More about Dr. Kelly

References

1.   Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068. doi:10.1097/GME.0000000000000329

2.   Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–756. doi:10.1056/NEJM199309093291102

3.   The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. doi:10.1097/GME.0000000000001609